Astrotech (NASDAQ:ASTC) Rating Lowered to “Strong Sell” at Wall Street Zen

Astrotech (NASDAQ:ASTC) was downgraded by stock analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research report issued on Monday.

Separately, Weiss Ratings upgraded Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Astrotech Stock Performance

Shares of NASDAQ ASTC opened at $7.73 on Monday. Astrotech has a 1 year low of $1.91 and a 1 year high of $68.85. The firm has a market cap of $13.91 million, a P/E ratio of -0.92 and a beta of 4.77. The firm’s 50 day moving average price is $14.24 and its 200 day moving average price is $7.06.

Astrotech (NASDAQ:ASTC) last announced its quarterly earnings data on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%. The business had revenue of $0.34 million during the quarter.

Hedge Funds Weigh In On Astrotech

Several hedge funds and other institutional investors have recently made changes to their positions in ASTC. J. Safra Sarasin Holding AG acquired a new stake in Astrotech in the 1st quarter valued at $140,000. DRW Securities LLC lifted its stake in shares of Astrotech by 168.5% during the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after purchasing an additional 19,747 shares in the last quarter. Finally, Susquehanna International Group LLP acquired a new position in shares of Astrotech during the third quarter worth about $66,000. Institutional investors and hedge funds own 24.35% of the company’s stock.

Astrotech Company Profile

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.